Sodium Butyrate is available in white free flowing powder soluble in water. It is used in pharmaceutical drugs to improve passive absorption of water in the colon. Also improves cognitive function in Schizophrenia. Another use is feed additives to prevent colon cancer in animals, and many more.
Molecular Formula – CH3CH2CH2COONa
Molecular Weight – 110.09 gm/mol
CAS No – 156-54-7
Shelf Life – 36 months
HSN Code – 2915.6010
Packing Size – 20/25 kg in HDPE bag/drum
Storage Condition – Keep Well Closed, protected against light, dry and at room temperature
Additional Info – 1. Avilable as powder & coated (different %)
2. Available as USP, food grade, feed grade
3. Documents available
| Sl. No. | PARAMETER | SPECIFICATION |
| 1. | Description | White free flowing powder, with occasional friable lump, odour characteristic. |
| 2. | Solubility | Soluble in water |
| 3. | Identification | Positive for Sodium & Butyric Acid. |
| 4. | pH (of 10% solution in water) | 7.0 – 11.0 |
| 5. | Heavy Metals (as Lead) | NMT 10 ppm |
| 6. | Arsenic | NMT 3 ppm |
| 7. | LOD (at 105°C till constant weight) | NMT 3.0% w/w |
| 8. | Assay (On Dried Basis) | 98.0% w/w – 101.0% w/w |
| Category | Description |
|---|---|
| Veterinary | It is used as supplement which are mainly for veterinary purposes. |
Abstract Maternal nutrition, gut microbiome composition, and metabolites derived from gut microbiota are closely related to the development of hypertension in offspring. A plethora of metabolites generated from diverse tryptophan metabolic pathways show both beneficial and harmful effects. Butyrate, one...
Read moreABSTRACT Chemically protected sodium butyrate (CSB) is a new kind of sodium butyrate. Our previous study found that 1,000 mg/kg of CSB had the potential capacity of improving growth performance and promoting early development of small intestine in broilers. This...
Read moreAbstract Inflammation and fibrosis are the important pathophysiologic processes in diabetic kidney disease (DKD), which is induced by epigenetics, especially histone posttranslational modification (HPTMs). Recent reports highlighted that butyrate, one of the short-chain fatty acids (SCFAs) primarily originated from the...
Read moreAbstract in English, Chinese Metabolic-associated fatty liver disease (MAFLD) has become the most common chronic liver disease affecting global public health, and its incidence rate is increasing year by year. The molecular mechanism of its pathogenesis is not yet fully...
Read moreAbstract Rationale: Energy metabolism disorder is a widespread feature that exists in the early clinical stages of Alzheimer's disease (AD). Astrocyte is the most numerous and the largest glial cell in the brain. By transporting energetic fuels such as lactate...
Read moreAbstract Background: Butyrate has shown anti-inflammatory and regenerative properties, providing symptomatic relief when orally supplemented in patients suffering from various colonic diseases. We investigated the effect of a colonic-delivery formulation of butyrate on the fecal microbiota of patients with inflammatory...
Read moreAbstract Accumulating evidence suggests that selected microbiota-derived metabolites play a significant role in both tumor prevention and supportive treatment of cancer. Short-chain fatty acids (SCFAs), i.e., mainly acetate, proprionate, and butyrate, are one of them. Nowadays, it is known that...
Read more